TERN Announces $5.7B Merck Acquisition, $53.00/Share Cash Deal, 31% Premium, Orphan Drug Designation for TERN-701 CML Therapy
Terns Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $52.95
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS